Preferential mammary carcinogenic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhlP) in human c-Ha-ras proto-oncogene transgenic rats

Cancer Science

Volumn 95, Issue 5, 2004, Pages 399-403

  Naito, Akihiro ^a   Suzuki, Akane ^a   Ueda, Shinobu ^a   Nomoto, Hiroshi ^a   Toriyama Baba, Hiroyasu ^a   Asamoto, Makoto ^a,b   Tsuda, Hiroyuki ^a,b  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; CASEIN; ONCOPROTEIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; BREAST CARCINOGENESIS; BREAST CELL; BREAST SARCOMA; BREAST TUMOR; CANCER SUSCEPTIBILITY; CARCINOSARCOMA; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENE MUTATION; IMMUNOREACTIVITY; MALE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROTO ONCOGENE; RAT; RAT STRAIN; TRANSGENE; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; DNA, NEOPLASM; DOWN-REGULATION; FEMALE; GENES, RAS; GENETIC PREDISPOSITION TO DISEASE; IMIDAZOLES; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; POLYMERASE CHAIN REACTION; RATS;

EID: 3042549547     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2004.tb03222.x     Document Type: Article

References (43)

1. Bos JL. ras oncogenes in human cancer: a review. Cancer Res 1989; 49: 4682-9.
2. Balmain A, Brown K. Oncogene activation in chemical carcinogenesis. Adv Cancer Res 1988; 51: 147-82.
3. Matsumoto K, Iwase T, Hirono I, Nishida Y, Iwahori Y, Hori T, Asamoto M, Takasuka N, Kim DJ, Ushijima T, Nagao M, Tsuda H. Demonstration of ras and p53 gene mutations in carcinomas in the forestomach and intestine and soft tissue sarcomas induced by N-methyl-N-nitrosourea in the rat. Jpn J Cancer Res 1997; 88: 129-36.
4. Sukumar S, Notario V, Martin-Zanca D, Barbacid M. Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations. Nature 1983; 306: 658-61.
5. Zhang R, Haag JD, Gould MN. Reduction in the frequency of activated ras oncogenes in rat mammary carcinomas with increasing N-methyl-N-nitrosourea doses or increasing prolactin levels. Cancer Res 1990; 50: 4286-90.
6. Zhang R, Haag JD, Gould MN. Quantitating the frequency of initiation and cH-ras mutation in in situ N-methyl-N-nitrosourea-exposed rat mammary gland. Cell Growth Differ 1991; 2: 1-6.
7. Jacoby RF, Alexander RJ, Raicht RF, Brasitus TA. K-ras oncogene mutations in rat colon tumors induced by N-methyl-N-nitrosourea. Carcinogenesis 1992; 13: 45-9.
8. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ, Vogelstein B. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987; 327: 293-7.
9. Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987; 327: 298-303.
10. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988; 53: 549-54.
11. Rashid A. Cellular and molecular biology of biliary tract cancers. Surg Oncol Clin N Am 2002; 11: 995-1009.
12. Bos JL, Verlaan-de Vries M, van der Eb AJ, Janssen JW, Delwel R, Lowenberg B, Colly LP. Mutations in N-ras predominate in acute myeloid leukemia. Blood 1987; 69: 1237-41.
13. Asamoto M, Ochiya T, Toriyama-Baba H, Ota T, Sekiya T, Terada M, Tsuda H. Transgenic rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis. Carcinogenesis 2000; 21: 243-9.
14. Tsuda H, Asamoto M, Ochiya T, Toriyama-Baba H, Naito A, Ota T, Sekiya T, Terada M. High susceptibility of transgenic rats carrying the human c-Ha-ras proto-oncogene to chemically-induced mammary carcinogenesis. Mutat Res 2001; 477: 173-82.
15. Ota T, Asamoto M, Toriyama-Baba H, Yamamoto F, Matsuoka Y, Ochiya T, Sekiya T, Terada M, Akaza H, Tsuda H. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis. Carcinogenesis 2000; 21: 1391-6.
16. Asamoto M, Toriyama-Baba H, Ohnishi T, Naito A, Ota T, Ando A, Ochiya T, Tsuda H. Transgenic rats carrying human c-Ha-ras proto-oncogene are highly susceptible to N-nitrosomethylbenzylamine induction of esophageal tumorigenesis. Jpn J Cancer Res 2002; 93: 744-51.
17. Nagao M, Wakabayashi K, Ushijima T, Toyota M, Totsuka Y, Sugimura T. Human exposure to carcinogenic heterocyclic amines and their mutational fingerprints in experimental animals. Environ Health Perspect 1996; 3: 497-501.
18. Layton DW, Bogen KT, Knize MG, Hatch FT, Johnson VM, Felton JS. Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis 1995; 16: 39-52.
19. Ito N, Hasegawa R, Sano M, Tamano S, Esumi H, Takayama S, Sugimura T. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis 1991; 12: 1503-6.
20. Ghoshal A, Preisegger KH, Takayama S, Thorgeirsson SS, Snyderwine EG. Induction of mammary tumors in female Sprague-Dawley rats by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-blpyridine and effect of dietary fat. Carcinogenesis 1994; 15: 2429-33.
21. Nagao M, Ushijima T, Wakabayashi K, Ochiai M, Kushida H, Sugimura T, Hasegawa R, Shirai T, Ito N. Dietary carcinogens and mammary carcinogenesis. Induction of rat mammary carcinomas by administration of heterocyclic amines in cooked foods. Cancer 1994; 74: 1063-9.
22. Adamson RH, Thorgeirsson UP, Sugimura T. Extrapolation of heterocyclic amine carcinogenesis data from rodents and nonhuman primates to humans. Arch Toxicol Suppl 1996; 18: 303-18.
23. Sinha R. An epidemiologic approach to studying heterocyclic amines. Mutat Res 2002; 507: 197-204.
24. Nagao M, Ushijima T, Watanabe N, Okochi E, Ochiai M, Nakagama H, Sugimura T. Studies on mammary carcinogenesis induced by a heterocyclic amine, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, in mice and rats. Environ Mol Mutagen 2002; 39: 158-64.
25. Sutherland LA, Bird RP. The effect of chenodeoxycholic acid on the development of aberrant crypt foci in the rat colon. Cancer Lett 1994; 76: 101-7.
26. Hirayama Y, Wakazono K, Yamamoto M, Kitano M, Tatematsu M, Nagao M, Sugimura T, Ushijima T. Rare mutations of p53, Ki-ras, and beta-catenin genes and absence of K-sam and c-erbB-2 amplification in N-methyl-N′-nitro-N-nitrosoguanidine-induced rat stomach cancers. Mol Carcinog 1999; 25: 42-7.
27. Asamoto M, Ota T, Toriyama-Baba H, Hokaiwado N, Naito A, Tsuda H. Mammary carcinomas induced in human c-Ha-ras proto-oncogene transgenic rats are estrogen-independent, but responsive to d-limonene treatment. Jpn J Cancer Res 2002; 93: 32-5.
28. Han BS, Fukamachi K, Takasuka N, Ohnishi T, Maeda M, Yamasaki T, Tsuda H. Inhibitory effects of 17beta-estradiol and 4-n-octylphenol on 7,12-dimethylbenz[a]anthracene-induced mammary tumor development in human c-Ha-ras proto-oncogene transgenic rats. Carcinogenesis 2002; 23: 1209-15.
29. Russo J, Wilgus G, Russo IH. Susceptibility of the mammary gland to carcinogenesis. I. Differentiation of the mammary gland as determinant of tumor incidence and type of lesion. Am J Pathol 1979; 96: 721-36.
30. Russo J, Tait L, Russo IH. Susceptibility of the mammary gland to carcinogenesis. III. The cell of origin of rat mammary carcinoma. Am J Pathol 1983; 113: 50-66.
31. Russo J, Russo IH. Experimentally induced mammary tumors in rats. Breast Cancer Res Treat 1996; 39: 7-20.
32. Matsuoka Y, Fukamachi K, Hamaguchi T, Toriyama-Baba H, Kawaguchi H, Kusunoki M, Yoshida H, Tsuda H. Rapid emergence of mammary preneoplastic and malignant lesions in human c-Ha-ras proto-oncogene transgenic rats: possible application for screening of chemopreventive agents. Toxicol Pathol 2003; 31: 632-7.
33. Snyderwine EG. Mammary gland carcinogenesis by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rats: possible mechanisms. Cancer Lett 1999; 143: 211-5.
34. Russo IH, Russo J. Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol Neoplasia 1998; 3: 49-61.
35. Tsubura A, Izuno Y, Shoji T, Kusunose N, Morii S. Influence of strain and sex on the local development of mammary tumors induced by direct application of DMBA powder to rat mammary glands. Acta Pathol Jpn 1990; 40: 9-13.
36. Oft M, Peli J, Rudaz C, Schwarz H, Beug H, Reichmann E. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 1996; 10: 2462-77.
37. Zatelli MC, Rossi R, degli Uberti EC. Androgen influences transforming growth factor-beta1 gene expression in human adrenocortical cells. J Clin Endocrinol Metab 2000; 85: 847-52.
38. Ushijima T, Kakiuchi H, Makino H, Hasegawa R, Ishizaka Y, Hirai H, Yazaki Y, Ito N, Sugimura T, Nagao M. Infrequent mutation of Ha-ras and p53 in rat mammary carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Mol Carcinog 1994; 10: 38-44.
39. Jasin M. Homologous repair of DNA damage and tumorigenesis: the BRCA connection. Oncogene 2002; 21: 8981-93.
40. Castilla LH, Couch FJ, Erdos MR, Hoskins KF, Calzone K, Garber JE, Boyd J, Lubin MB, Deshano ML, Brody LC et al. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat Genet 1994; 8: 387-91.
41. Inoue R, Fukutomi T, Ushijima T, Matsumoto Y, Sugimura T, Nagao M. Germline mutation of BRCA1 in Japanese breast cancer families. Cancer Res 1995; 55: 3521-4.
42. Martin AM, Weber BL. Genetic and hormonal risk factors in breast cancer. J Natl Cancer Inst 2000; 92: 1126-35.
43. Okochi E, Miyamoto K, Wakazono K, Shima H, Sugimura T, Ushijima T. Reduced Brca1 protein expression in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary carcinomas. Mol Carcinog 2002; 34: 211-8.